The Arizona Rural & Public Health Policy Forum is designed to address current rural and public health policy issues and their impact on Arizona’s rural and tribal communities, provide information on organizations’ legislative priorities for the upcoming session, and facilitate networking opportunities. Please note that this is an in-person event. Portions of the event will be recorded for later viewing, but there will be no live streaming of the event.

Read on eventbrite.com

The Arizona Rural & Public Health Policy Forum is designed to address current rural and public health policy issues and their impact on Arizona’s rural and tribal communities, provide information on organizations’ legislative priorities for the upcoming session, and facilitate networking opportunities.

Read on eventbrite.co.uk

Discover thousands of medical products and solutions that are changing the healthcare landscape live and in-person at the Dubai World Trade Centre from 30 January - 2 February 2023 and online from 4 January - 2 March 2023. Long established as the ‘must attend’ event in our region, we attract regional and international healthcare professionals who value the power of learning, networking and business. Bringing together policy drivers, thought leaders, healthcare professionals and decision-makers in order to address healthcare's most pressing challenges through collaboration and empowerment.

Read on arabhealthonline.com

With 10 million people worldwide living with IBD, there is an urgent need to move away from a one-size-fits-all standard of care and invest in the use of precision medicine to make informed decisions through patient selection and clinical monitoring, to reduce cost of care, prevent relapses and achieve long term remission.

Uniting experts across pharma, biotech and academia, the Precision Medicine in Inflammatory Bowel Disease Summit is your only dedicated forum to benchmark novel markers and innovative technology across RNA-sequencing, metabolomics, proteomics and more. Be involved in this cross-indication collaboration to translate basic immunology into clinical response and develop your biomarker strategy early.

Developed in collaboration with key industry thought leaders from AbbVie, Celsius Therapeutics, Crohn's and Colitis Foundation, Janssen, Prometheus Bioscience and more, leave this meeting with key lessons learned to improve your clinical trial efficacy, and patient care for those suffering with IBD.

Read on go.evvnt.com

These past few years have marked the acceleration of the adoption of in silico techniques for more efficient and innovative clinical research. When embarking on a new R&D program, scientists face a strategic imperative to assemble the best and most relevant available data and insights. Jinkō, Novadiscovery’s in silico clinical trial simulation platform, has been designed to build and maintain a high-quality knowledge repository, allowing teams to seamlessly cooperate, both internally and with external thought leaders. During the first part of this webinar, featured speaker Dr. Friehs, will explain her role and how she uses jinkō with her fellows to extract, classify and qualify pieces of knowledge in a systematic, transparent and traceable manner, and use these in research reports and literature reviews. After that, featured speaker Frédéric (CPO of Novadiscovery) will showcase how this knowledge is then leveraged directly within jinkō to help lower cost and ethical constraints as well as achieve greater trial efficiency through the design and simulation of in silico trials. This will be illustrated with two practical use cases using Nova’s non-small cell lung cancer (NSCLC) disease model of epidermal growth factor receptor (EGFR) mutated lung adenocarcinoma (LUAD). First, by exploring a large range of doses and then by testing eligibility criteria refinement and its impact on treatment effectiveness. Join this webinar to learn more about using a clinical trial simulation platform to generate auditable and reproducible digital evidence.

Join this webinar to learn more about using an in silico clinical trial simulation platform to generate auditable and reproducible digital evidence.

Read on xtalks.dryfta.com

As employers continue to balance reducing health care costs with improving employee engagement, identifying what works and what doesn't can feel impossible. The Health Benefits Conference & Expo is designed to help you do just that. Using employer case studies that offer proven solutions and insights from experts paving the way in their organizations, HBCE will guide you in identifying the right formula for positive outcomes at your organization.

Read on ifebp.org

The diagnosis, management, and prevention of common rhythm disorders, atrial fibrillation, and ventricular arrhythmias will be reviewed along with challenging aspects of congestive heart failure, coronary artery disease, valvular heart disease, and myocardial disease. There will be an emphasis on patient management, case-based presentations, and panel discussion sessions to provide interaction between the faculty and attendees. Mayo Clinic and guest faculty will share "pearls" to aid in the evaluation and assessment of patients with commonly seen cardiovascular diseases. Special sessions will highlight ECG pearls useful in all aspects of cardiology.

Time: 7:00 am - 12:30 pm

Exploit Understanding of TGF-β Biology, Harness Clinically Validated Biomarkers & Advance Safe & Efficacious Clinical Programs for Maximal Therapeutics Benefit in Immuno-Oncology.

 In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine.

From uncovering the effects and production of TGF-β in immune, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β.

Tailored with 18+ senior leaders, the 2023 meeting will be taking place in-person for the first time - don't miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology!

 Whether you are new to this field or a seasoned expert, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.

Read on go.evvnt.com

Exploit Understanding of TGF-β Biology, Harness Clinically Validated Biomarkers & Advance Safe & Efficacious Clinical Programs for Maximal Therapeutics Benefit in Immuno-Oncology.

In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine.

From uncovering the effects and production of TGF-β in immune, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β.

Tailored with 18+ senior leaders, the 2023 meeting will be taking place in-person for the first time - don't miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology!

Whether you are new to this field or a seasoned expert, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.

Read on summit.com

Mayo Clinic's Selected Topics in Internal Medicine (STIM) is a postgraduate course designed to update general internists, internist-subspecialists, family medicine specialists, and other primary healthcare professionals on selected internal medicine topics. Some of the most common problems encountered in clinical practice are represented. Course focus is clinical pearls and practice updates. Presentations are made by experts from various disciplines in internal medicine and faculty members are available during breaks to answer questions and to discuss cases with course participants.

Upon completion of this activity, participants should be able to:

Summarize recent updates, clinical studies, and new guidelines that impact practice in general medicine.

Review updates and clinical practice strategies in the areas of general internal medicine, gastroenterology, infectious diseases, endocrinology, rheumatology, dermatology, cardiology, pulmonology, hematology, geriatrics, perioperative medicine, psychiatry and neurology.

Describe management options for diabetes and evidence for new diabetic agents.

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Grand Hyatt Kauai Resort and Spa

1571 Poipu Road

Koloa, HI 96756

United States

Price:

General Admission Live: USD 1249.00

Speakers: Christopher (Chris) R. Stephenson, M.D., John B. Bundrick, M.D.

Date and Time: 30th January 2023 at 7:00 am to 3rd February 2023 at 12:00 pm